Ausgabe 1/2017
Inhalt (27 Artikel)
The relationship between statins and breast cancer prognosis varies by statin type and exposure time: a meta-analysis
Binliang Liu, Zongbi Yi, Xiuwen Guan, Yi-Xin Zeng, Fei Ma
Ablative Therapies in Metastatic Breast Cancer: A Systematic Review
Michael Jonathan Kucharczyk, Sameer Parpia, Cindy Walker-Dilks, Laura Banfield, Anand Swaminath
Prolactin/androgen-inducible carboxypeptidase-D increases with nitrotyrosine and Ki67 for breast cancer progression in vivo, and upregulates progression markers VEGF-C and Runx2 in vitro
Lynn N. Thomas, Emily R. Chedrawe, Penelope J. Barnes, Catherine K. L. Too
MMP11 and CD2 as novel prognostic factors in hormone receptor-negative, HER2-positive breast cancer
Jinil Han, Yoon-La Choi, Haein Kim, Jun Young Choi, Se Kyung Lee, Jeong Eon Lee, Joon-Seok Choi, Sarah Park, Jong-Sun Choi, Young Deug Kim, Seok Jin Nam, Byung-Ho Nam, Mi Jeong Kwon, Young Kee Shin
Poor prognosis of patients with triple-negative breast cancer can be stratified by RANK and RANKL dual expression
Monica E. Reyes, Takeo Fujii, Daniel Branstetter, Savitri Krishnamurthy, Hiroko Masuda, Xiaoping Wang, James M. Reuben, Wendy A. Woodward, Beatrice J. Edwards, Gabriel N. Hortobagyi, Debu Tripathy, William C. Dougall, Bedrich L. Eckhardt, Naoto T. Ueno
Gait, balance, and patient-reported outcomes during taxane-based chemotherapy in early-stage breast cancer patients
Scott M. Monfort, Xueliang Pan, Robyn Patrick, Bhuvaneswari Ramaswamy, Robert Wesolowski, Michelle J. Naughton, Charles L. Loprinzi, Ajit M. W. Chaudhari, Maryam B. Lustberg
Changes in arm tissue composition with slowly progressive weight-lifting among women with breast cancer-related lymphedema
Xiaochen Zhang, Justin C. Brown, Electra D. Paskett, Babette S. Zemel, Andrea L. Cheville, Kathryn H. Schmitz
Discerning the clinical relevance of biomarkers in early stage breast cancer
Tarah J. Ballinger, Nawal Kassem, Fei Shen, Guanglong Jiang, Mary Lou Smith, Elda Railey, John Howell, Carol B. White, Bryan P. Schneider
MRI predicts pathologic complete response in HER2-positive breast cancer after neoadjuvant chemotherapy
Mette S. van Ramshorst, Claudette E. Loo, Emilie J. Groen, Gonneke H. Winter-Warnars, Jelle Wesseling, Frederieke van Duijnhoven, Marie-Jeanne T. Vrancken Peeters, Gabe S. Sonke
Frailty and long-term mortality of older breast cancer patients: CALGB 369901 (Alliance)
Jeanne S. Mandelblatt, Ling Cai, George Luta, Gretchen Kimmick, Jonathan Clapp, Claudine Isaacs, Brandeyln Pitcher, William Barry, Eric Winer, Stephen Sugarman, Clifford Hudis, Hyman Muss, Harvey J. Cohen, Arti Hurria
Adherence to guidelines and breast cancer patients survival: a population-based cohort study analyzed with a causal inference approach
Anita Andreano, Paola Rebora, Maria Grazia Valsecchi, Antonio Giampiero Russo
Estrogen and progesterone receptor expression levels do not differ between lobular and ductal carcinoma in patients with hormone receptor-positive tumors
Wilfred Truin, Rudi M. H. Roumen, Sabine Siesling, Koen K. van de Vijver, Vivianne C. G. Tjan-Heijnen, Adri C. Voogd
Breast cancer in Asian Americans in California, 1988–2013: increasing incidence trends and recent data on breast cancer subtypes
Scarlett Lin Gomez, Julie Von Behren, Meg McKinley, Christina A. Clarke, Salma Shariff-Marco, Iona Cheng, Peggy Reynolds, Sally L. Glaser
Omitting re-excision for focally positive margins after breast-conserving surgery does not impair disease-free and overall survival
Elvira L. Vos, Sabine Siesling, Margreet H.A. Baaijens, Cornelis Verhoef, Agnes Jager, Adri C. Voogd, Linetta B. Koppert
Sleep quality, duration, and breast cancer aggressiveness
Allison Soucise, Caila Vaughn, Cheryl L. Thompson, Amy E. Millen, Jo L. Freudenheim, Jean Wactawski-Wende, Amanda I. Phipps, Lauren Hale, Lihong Qi, Heather M. Ochs-Balcom
Role of taxanes in chemotherapy-related cognitive impairment: A prospective longitudinal study
Noemí Cerulla, Àngels Arcusa, José-Blas Navarro, Maite Garolera, Cristina Enero, Glòria Chico, Luís Fernández-Morales
SLCO1B1 polymorphisms and plasma estrone conjugates in postmenopausal women with ER+ breast cancer: genome-wide association studies of the estrone pathway
Tanda M. Dudenkov, James N. Ingle, Aman U. Buzdar, Mark E. Robson, Michiaki Kubo, Irada Ibrahim-zada, Anthony Batzler, Gregory D. Jenkins, Tracy L. Pietrzak, Erin E. Carlson, Poulami Barman, Matthew P. Goetz, Donald W. Northfelt, Alvaro Moreno-Aspita, Clark V. Williard, Krishna R. Kalari, Yusuke Nakamura, Liewei Wang, Richard M. Weinshilboum
Squamous cell carcinoma of the breast in the United States: incidence, demographics, tumor characteristics, and survival
Siddhartha Yadav, Dhiraj Yadav, Dana Zakalik
DNA methylation age is elevated in breast tissue of healthy women
Mary E. Sehl, Jill E. Henry, Anna Maria Storniolo, Patricia A. Ganz, Steve Horvath
Differential impact of hormone receptor status on survival and recurrence for HER2 receptor-positive breast cancers treated with Trastuzumab
Andrew McGuire, Olga Kalinina, Emma Holian, Catherine Curran, Carmel A. Malone, Ray McLaughlin, Aoife Lowery, James A. L. Brown, Michael J. Kerin
Immediate tissue expander or implant-based breast reconstruction does not compromise the oncologic delivery of post-mastectomy radiotherapy (PMRT)
Krishan R. Jethwa, Mohamed M. Kahila, Thomas J. Whitaker, William S. Harmsen, Kimberly S. Corbin, Sean S. Park, Elizabeth S. Yan, Valerie Lemaine, Judy C. Boughey, Robert W. Mutter
Racial disparity in vitamin D status may explain racial disparity in survival from estrogen and progesterone receptor-positive breast cancer
William B. Grant
The value of algorithms predicting the Oncotype DX recurrence score should not be underestimated!
Bradley Turner, Ping Tang, David Hicks
Erratum to: Effective treatment of intractable cutaneous metastases of breast cancer with electrochemotherapy: a useful contributor to cutaneous disease control
M. Bourke, D. Soden, A. J. P. Clover